TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank67
3Y CAGR+4.7%
5Y CAGR+35.7%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+4.7%/yr
Annual compound
5Y CAGR
+35.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $228.79M | -38.4% |
| 2024 | $371.12M | +36.4% |
| 2023 | $272.15M | +36.7% |
| 2022 | $199.09M | +5.8% |
| 2021 | $188.11M | +278.2% |
| 2020 | $49.74M | +0.7% |
| 2019 | $49.38M | - |